Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining

被引:13
|
作者
Luo, Jiao [1 ]
Zhang, Wang [1 ]
Su, Cailing [1 ]
Zhou, Zhanmei [1 ]
Wang, Guobao [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Renal Div,State Key Lab Organ Failure Res, Guangzhou, Peoples R China
关键词
PLA2R antibody; PLA2R antigen; PLA2R-associated MN; renal pathologic chronicity lesions; PHOSPHOLIPASE-A2 RECEPTOR AUTOANTIBODIES; ANTI-PLA(2)R AUTOANTIBODIES; GLOMERULAR DEPOSITS; KIDNEY BIOPSY; ANTIBODIES; DIAGNOSIS; ANTIGEN;
D O I
10.1093/ndt/gfaa239
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Serum phospholipase A2 receptor (PLA2R) anti-body (SAb) and glomerular deposits of PLA2R antigen (GAg) have been tested widely in idiopathic membranous nephropathy (MN). Recently, we noticed a special form of PLA2R-associated MN with positive circulating PLA2R antibody but negative PLA2R deposits in the glomeruli by immunofluorescence on frozen tissue (IF-F). The significance of this form of PLA2R-associated MN is yet to be elucidated. This study aimed to explore the clinicopathological features of these PLA2R-associated MN patients. Methods. This study enrolled 229 biopsy-proven PLA2R-associated MN patients with SAb+. SAb was measured by enzyme-linked immunosorbent assay, and GAg was detected by IF-F. These patients were divided into SAb+/GAg+ and SAb+/GAg- groups. Clinicopathological characteristics of SAb+/GAg+ and SAb+/GAg- PLA2R-associated MN patients were compared. PLA2R antigens of 19 SAb+/GAg- PLA2R-associated MN patients were verified by immunohistochemistry on paraffin tissue (IHC-P). Results. Among 229 SAb+ PLA2R-associated MN patients, 210 (91.70%) were GAg+ and 19 (8.3%) were GAg-. These 19 SAb+/GAg- PLA2R-associated MN patients presented positive PLA2R deposits by IHC-P. Compared with SAb+/GAg+ PLA2R-associated MN patients, SAb+/GAg- PLA2R-associated MN patients had higher levels of serum PLA2R anti-body (P = 0.004), increased proteinuria (P = 0.008), lower serum albumin (P = 0.019), more prominent chronic pathological lesions in terms of glomerulosclerosis score (P = 0.025), interstitial fibrosis score (P = 0.016), tubular atrophy score (P = 0.010) and total renal chronicity score (P = 0.010), and were more likely to be accompanied by focal segmental glomerulosclerosis (P = 0.014). Higher SAb level was associated with the total renal chronicity score (odds ratio per 100 RU/mL, 1.16; 95% confidence interval 1.01-1.33; P = 0.033). Conclusions. PLA2R-associated MN patients with seropositive PLA2R antibody but negative PLA2R deposits in the glomeruli by IF-F have higher levels of SAb and worse clinicopathological manifestations compared with their double-positive counterparts. IHC-P can be an alternative technique to reveal PLA2R glomerular deposits.
引用
收藏
页码:2216 / 2223
页数:8
相关论文
共 50 条
  • [1] Clinicopathological Characteristics and Outcomes of PLA2R-Associated Membranous Nephropathy in Seropositive Patients Without PLA2R Staining on Kidney Biopsy
    Luo, Jiao
    Yuan, Ye
    Tian, Jianwei
    Zhou, Zhanmei
    Su, Cailing
    Yang, Fang
    Wang, Guobao
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (03) : 364 - 372
  • [2] The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification
    Hu, Xiaofan
    Wang, Xinlu
    Yu, Xialian
    Ni, Liyan
    Gao, Chenni
    Pan, Xiaoxia
    Ren, Hong
    Xu, Jing
    Ma, Jun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [3] Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies
    Li, Xue
    Shen, Yang
    Li, Yanchun
    Ma, Lijie
    Sun, Qianmei
    RENAL FAILURE, 2024, 46 (01)
  • [4] Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy A Validation Study
    Bobart, Shane A.
    Han, Heedeok
    Tehranian, Shahrzad
    De Vriese, An S.
    Roman, Juan Carlos Leon
    Sethi, Sanjeev
    Zand, Ladan
    Andrades Gomez, Cristina
    Giesen, Callen D.
    Soler, Maria Jose
    Bomback, Andrew S.
    Fervenza, Fernando C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (12): : 1833 - 1839
  • [5] The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
    Chen, Yang
    Xu, Ying
    Chen, Siyu
    Yu, Yedong
    Zhu, Xueling
    Chen, Jianghua
    RENAL FAILURE, 2023, 45 (02)
  • [6] The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
    Bajcsi, Dora
    Bito, Laszlo
    Turkevi-Nagy, Sandor
    Nyari, Tibor
    Kemeny, Eva
    Legrady, Peter
    abraham, Gyorgy
    Ivanyi, Bela
    BMC NEPHROLOGY, 2023, 24 (01)
  • [7] The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
    McDonnell, Thomas
    Wu, Henry H. L.
    Sinha, Smeeta
    Chinnadurai, Rajkumar
    GENES, 2023, 14 (07)
  • [8] Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy
    Burbelo, Peter D.
    Joshi, Megha
    Chaturvedi, Adrija
    Little, Dustin J.
    Thurlow, John S.
    Waldman, Meryl
    Olson, Stephen W.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01): : 208 - 217
  • [9] Response to immunosuppressive therapy in PLA2R-associated and non-PLA2R-associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
    Wang, Jia
    Xie, Qionghong
    Sun, Zhuxing
    Xu, Ningxin
    Li, Yan
    Wang, Liang
    Liu, Shaojun
    Xue, Jun
    Hao, Chuan-Ming
    BMC NEPHROLOGY, 2017, 18
  • [10] PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis
    Dhaouadi, Tarak
    Abdellatif, Jihen
    Trabelsi, Raja
    Gaied, Hanene
    Chamkhi, Sameh
    Sfar, Imen
    Goucha, Rym
    Ben Hamida, Fethi
    Ben Abdallah, Taieb
    Gorgi, Yousr
    PLOS ONE, 2020, 15 (10):